Skip to main content
TipRanks
Go Ultimate75% OFF

Pharmarise Holdings Corp. (2796) Income Statement

0 Followers

Pharmarise Holdings Corp. Income Statement

Last quarter (Q1 2026), Pharmarise Holdings Corp.'s total revenue was ¥17.24B, an increase of 2.92% from the same quarter last year. In Q1, Pharmarise Holdings Corp.'s net income was ¥-37.00M. See Pharmarise Holdings Corp.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementMay 25May 24May 23May 22May 21
¥ 69.51B¥ 63.51B¥ 54.47B¥ 52.03B¥ 51.61B
¥ 8.64B¥ 8.20B¥ 7.89B¥ 7.50B¥ 7.42B
¥ 7.66B¥ 7.91B¥ 6.98B¥ 6.06B¥ 5.90B
Depreciation and Amortization¥ 1.60B¥ 1.49B¥ 1.17B¥ 1.22B¥ 1.31B
¥ 2.58B¥ 1.68B¥ 1.38B¥ 2.33B¥ 2.69B
¥ 980.00M¥ 295.00M¥ 916.00M¥ 1.44B¥ 1.52B
¥ -282.00M¥ -287.00M¥ -773.00M¥ -390.00M¥ -199.00M
¥ 698.00M¥ 8.00M¥ 143.00M¥ 1.05B¥ 1.32B
¥ 113.00M¥ -368.00M¥ -351.00M¥ 333.00M¥ 448.00M
Per Share Metrics
Basic EPS¥ 9.95¥ -32.42¥ -33.35¥ 35.42¥ 47.90
Diluted EPS¥ 9.56¥ -32.42¥ -33.35¥ 26.86¥ 36.22
Weighted Average Shares Outstanding11.46M11.32M10.52M9.40M9.33M
Weighted Average Shares Outstanding (Diluted)11.92M11.32M10.52M12.47M12.40M

Currency in JPY

Pharmarise Holdings Corp. Earnings and Revenue History

-40B040B80B-0.8 %0 %0.8 %1.6 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin